Merrill Goozner has spent the last 25 years as a foreign correspondent, economics writer, and investigative reporter for publications such as The New York Times, The Washington Post, Columbia Journalism Review, and The Nation. Since 2003, Goozner has served as director of the Integrity of Science Project for the Center for Science in the Public Interest. He wrote about clinical trials of the anti-malarial artemisinin for our December 2006 cover story. Here, Goozner writes about a trip to Beija-Flor, Brazil, where he reported on the challenges of developing a vaccine against hookworm. The parasite enters through the skin, migrates to the bloodstream and lungs, where it gets coughed up, swallowed and lands in the intestines. "At first [the pathophysiology] is a little bit off-putting," he says. But, "as we got into the story, I lost my squeamishness."
After receiving a PhD in molecular biology in 1998, Andrew Moore served as ...
